Skip to main content

Treatment Clinical Trials for Medulloblastoma

Review the medulloblastoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-11 of 11

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Status: Active
Location: 95 locations
Molecular and Clinical Risk Directed Therapy for Infants and Young Children with Newly Diagnosed Medulloblastoma
Status: Active
Location: 10 locations
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Status: Active
Location: 7 locations
Digoxin for the Treatment of Pediatric and Young Adult Patients with Relapsed Non-SHH, Non-WNT Medulloblastoma
Status: Active
Location: 6 locations
A Peptide Vaccine (PEP-CMV) for the Treatment of Pediatric Patients with Newly Diagnosed High-Grade Glioma and Diffuse Intrinsic Pontine Glioma, or Recurrent, Refractory, or Progressive Medulloblastoma
Status: Active
Location: 4 locations
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Status: Active
Location: 6 locations
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Cellular Therapy (GPC2-CAR T-Cells) for the Treatment of Children and Young Adults with Relapsed or Refractory Medulloblastoma and other Central Nervous System Embryonal Tumors
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Adoptive Cell Therapy (TTRNA-xALT), Dendritic Cell Vaccine (TTRNA-DC), and Hematopoietic Stem Cells in Combination with Pembrolizumab for the Treatment of Relapsed or Progressive Group 3 or 4 Non-SHH/Non-WNT Medulloblastoma, MATCHPOINT Trial
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
WP1066 for the Treatment of Recurrent or Refractory and Progressive Malignant Brain Tumors
Status: Active
Location: Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia
Testing the Safety, Tolerability and Immunological Effects of SurVaxM in Children and Young Adults with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Status: Temporarily Closed to Accrual
Location: 13 locations